Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vialettes

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Diabete & Metabolisme|January 1, 1989
Stress antecedents and immune status in recently diagnosed type I (insulindependent) diabetes mellitusB Vialettes, J P Ozanon, S Kaplansky, et al.
La Revue De Medecine Interne|July 1, 1992
[Inflammatory rheumatism flare-up after surgical treatment of Cushing's disease: two cases]D Raccah, C Zeitoun, P Lafforgue, et al.
Diabetologia|June 1, 1992
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individualsC H Thivolet, M Tappaz, A Durand, et al.
European Journal of Endocrinology|October 20, 1999
Serum reg protein level is not related to the beta cell destruction/regeneration process during early phases of diabetogenesis in type I diabetesM A Christofilis, J Carrere, C Atlan-Gepner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1998
Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complicationsL Hermitte, C Atlan-Gepner, C Mattei, et al.
Biochemical and Biophysical Research Communications|November 4, 2000
Mitochondrial DNA variations in patients with maternally inherited diabetes and deafness syndromeD Perucca-Lostanlen, H Narbonne, J B Hernandez, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
Diabetes & Metabolism|October 29, 1997
PseudohypertriglyceridaemiaR Valero, C Atlan-Gepner, H Portugal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2009
Parallel increase of plasma apoproteins C-II and C-III in Type 2 diabetic patientsS Béliard, J P Nogueira, M Maraninchi, et al.
European Journal of Endocrinology|October 3, 1998
Study of serum big-insulin-like growth factor (IGF)-II and IGF binding proteins in two patients with extrapancreatic tumor hypoglycemia, using a combination of Western blotting methodsM A Christofilis, M Remacle-Bonnet, C Atlan-Gepner, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Diabete & Metabolisme|January 1, 1989
Stress antecedents and immune status in recently diagnosed type I (insulindependent) diabetes mellitusB Vialettes, J P Ozanon, S Kaplansky, et al.
La Revue De Medecine Interne|July 1, 1992
[Inflammatory rheumatism flare-up after surgical treatment of Cushing's disease: two cases]D Raccah, C Zeitoun, P Lafforgue, et al.
Diabetologia|June 1, 1992
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individualsC H Thivolet, M Tappaz, A Durand, et al.
European Journal of Endocrinology|October 20, 1999
Serum reg protein level is not related to the beta cell destruction/regeneration process during early phases of diabetogenesis in type I diabetesM A Christofilis, J Carrere, C Atlan-Gepner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1998
Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complicationsL Hermitte, C Atlan-Gepner, C Mattei, et al.
Biochemical and Biophysical Research Communications|November 4, 2000
Mitochondrial DNA variations in patients with maternally inherited diabetes and deafness syndromeD Perucca-Lostanlen, H Narbonne, J B Hernandez, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
Diabetes & Metabolism|October 29, 1997
PseudohypertriglyceridaemiaR Valero, C Atlan-Gepner, H Portugal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2009
Parallel increase of plasma apoproteins C-II and C-III in Type 2 diabetic patientsS Béliard, J P Nogueira, M Maraninchi, et al.
European Journal of Endocrinology|October 3, 1998
Study of serum big-insulin-like growth factor (IGF)-II and IGF binding proteins in two patients with extrapancreatic tumor hypoglycemia, using a combination of Western blotting methodsM A Christofilis, M Remacle-Bonnet, C Atlan-Gepner, et al.
Pageof 18